Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 298,513 | 258,991 | 266,619 | 271,298 | 260,598 |
| Cost of Goods | 56,358 | 47,674 | 46,059 | 47,289 | 47,819 |
| Gross Profit | 242,155 | 211,317 | 220,560 | 224,009 | 212,779 |
| Operating Expenses | 197,158 | 172,405 | 181,607 | 179,727 | 178,140 |
| Operating Income | 45,355 | 39,586 | 39,012 | 44,571 | 35,458 |
| Interest Expense | 1,377 | 217 | 21 | 22 | 22 |
| Other Income | 297 | 610 | 172 | 1,253 | 452 |
| Pre-tax Income | 44,275 | 39,979 | 39,163 | 45,802 | 35,888 |
| Income Tax | 13,769 | 12,002 | 12,611 | 15,048 | 11,666 |
| Net Income Continuous | 30,506 | 27,977 | 26,552 | 30,754 | 24,222 |
| Net Income | $30,506 | $27,977 | $26,552 | $30,754 | $24,222 |
| EPS Basic Total Ops | 1.45 | 1.33 | 1.24 | 1.40 | 1.09 |
| EPS Basic Continuous Ops | 1.45 | 1.33 | 1.24 | 1.40 | 1.09 |
| EPS Diluted Total Ops | 1.44 | 1.32 | 1.23 | 1.40 | 1.09 |
| EPS Diluted Continuous Ops | 1.44 | 1.32 | 1.23 | 1.39 | 1.09 |
| EBITDA(a) | $50,948 | $45,236 | $44,761 | $50,296 | $41,109 |